AI Selloff Appears Profit-Taking, Market Strategist Says
A leading market strategist argues the AI-led pullback is routine profit-taking after a rapid rally, with the AI infr...
Which Portfolio Is Better Sp 500 Equity Or Multi Asset Retirement
A side-by-side look at Sp 500 Equity and Multi Asset Retirement allocations, examining growth potential, risk, and diversification for retirement planning.
27,235 articles
Anthropic Won’t Lift Safeguards Amid Pentagon Dispute
A high-stakes clash between AI safety and national security is unfolding. Anthropic won’t lift safeguards even as the...
Strategic Education Insider Sells: Flat Stock Action
Insider moves can reveal much about a company’s outlook, but they aren’t a single data point. This article breaks dow...
Charles Hoskinson Goes All-In on Cardano and Midnight
Charles Hoskinson pivots back to Cardano as Midnight winds toward a close after a $250 million investment in Wyoming....
Forget Southern Copper: Domestic Copper King Moves Up
A sharp global copper crunch boosts Freeport-McMoRan as the leading domestic copper king. Investors eye FCX for cash ...
The Best Quantum Computing Stocks to Buy in March Now
As March arrives, the quantum computing space presents both risk and opportunity. This guide highlights two sturdy pi...
Google's Massive Win: OpenAI and the AI Video Frontier
A bold shift in AI strategy rewrite the investment thesis around Alphabet. OpenAI exits the AI video space, creating ...
Arm Holdings Faces Limited Upside After 177% Rally
Arm Holdings has surged this year on AI infrastructure bets, but a breather may be near as the company shows solid ea...
Micron Stock Price Prediction Signals Sell After 4x Rally
Micron Technology has unleashed a dramatic first half, but the market now eyes a cautious microns stock price predict...
SPX Technologies Jump as JPMorgan Initiates with Overweight
JPMorgan initiates SPX Technologies with an Overweight rating and a $260 target, signalling a favorable view on data-...
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Billion Reasons Love Nvidia: Why Investors Are Excited
Nvidia sits at the crossroads of AI, data centers, and gaming, powering a surge in demand that could push revenue wel...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status